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Background: It is not clear when to perform right atrial (RA) ablation in
patients with chronic AF (CAF). The objective of this study was to compare
the clinical and spectral characteristics of AF to identify predictors of RA
ablation to terminate AF. 
Methods: In 12 patients (age 65±6 years) with CAF, antral pulmonary vein
isolation and ablation of complex fractionated atrial electrograms (CFAEs)
were performed until AF terminated (within 120 minutes of radiofrequency
energy application). In this retrospective analysis, patients were categorized in
3 groups: Group 1) Termination of AF with left atrial (LA) ablation only
(n=3); Group 2) termination of AF with left and right atrial ablation (n=4); and
Group 3) No termination after left and right atrial ablation (n=5).  Clinical
characteristics and dominant frequency (DF) were compared at baseline and 1
min before termination of AF. 
Results: The 3 groups were similar for all clinical variables, except for
prior AF ablation which was more frequent in Group 2. (p=0.02). At baseline,
DF in V1 and CS were comparable in the 3 groups (Table). Only DF in the
CS before termination was significantly different among the 3 groups (p=0.04)
and may be predictive of the need for RA ablation in these patients with
chronic AF. 
Conclusion: Higher prevalence of repeat ablation procedures in patients
who needed right atrial ablation may indicate that, right atrial drivers are under
recognized during initial ablation. Therefore, right atrial drivers should be
sought after during redo procedures for AF.   
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Results of the CASA study: the automatic atrial capture management.
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(1) CHU Hopital SUD, Amiens, France - (2) Medtronic France, CRDM,
Boulogne-Billancourt, France
The CASA study has included 297 patients in France implanted with an
EnPulse® dual chamber pacemaker (Medtronic, Minneapolis, USA). Purpose
of this study is to compare manual atrial threshold (MAT) and threshold
assessed by the automatic atrial capture management function (ACM).
Methods: Patients are 76 +/- 10 years old; indications were atrio-ventricular
block (AVB) 70% and sinus dysfunction (SD) 30%; 31% had paroxystic atrial
arrhythmias before implantation. Measurement of P wave, manual atrial
threshold and atrial lead impedance have been performed at implantation,
before discharge, 6 to 12 weeks after and at 6 months follow-up. At each
follow-up automatic atrial thresholds are collected by interrogation of the
device via telemetry and compared with the manual values by R coefficient
correlation test.
Results: P wave amplitude and atrial lead impedance are stable during
follow-up without significant difference. Concerning atrial thresholds, there is
no difference between manual and automatic thresholds at each follow-up. R
coefficients are very high showing an excellent correlation between the two
methods.   
Conclusion: We have observed a very good correlation between atrial
threshold assessed by automatic atrial capture management function and
manual atrial threshold test.
(Voir tableau en bas de page) 
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que Bouchard, Marseille, France
Background and aim:  Patients implanted with dual chamber (DC)  pace-
makers (PM) have frequent episodes of arrhythmia.  The interest of memory
functions (MF) featuring EGM recordings to recognize and characterize these
arrhythmias, particularly at the ventricular level, is still not well evaluated.
The goal of this study is to establish the pertinence of MF at the ventricular
level by repeated analysis at follow-up of the data recorded in the PM memo-
ries.
Methods & Results: A prospective series of 405 patients (76 +/- 10 yrs),
M 59%, F 41% implanted with  DC Kappa  PMs (Medtronic, MN, USA) for
atrio-ventricular block (37%) and sinus dysfunction (50%) were seen at two
post implant semestrial follow-ups, at 6 months (F/u1) and at 12 months (F/
u2).  83 pts (20%) at F/u1 and/or F/u2 showed ventricular tachycardias (VT)
defined as at least 5 consecutive complexes at a frequency > 175 bpm for a
total of 102 follow-ups (17%).  55 pts (14%) showed VT at F/u1, 47 (12%) at
F/u2 and only 19 (5%) at both F/u1 and F/u2.  VT occurrence was statistically
independent from mode switch episodes from the atrial level.  Analysis
showed that age, pacing indication, pacing mode and cumulated percentage of
pacing are not factors in the presence of VT. In the VT group, 65% of patients
present cardiopathy, with an ejection fraction of 54 +/- 17%. We observe that
cardiopathy, is a statistical difference with the rest of the population of this
study (52%, p< 0.05). 
Conclusion: In our series, VT is frequent observed in 20% of PM patients
implanted for standard indications at 6 and 12 months follow-ups.  2/3 of these
patients show arrhythmia from the first 6 months f/u and 1/4 of these patients
at both 6 and 12 months f/u.  1 year of follow up seems to demonstrate best
sensitivity for VT detection. MF featuring EGM recordings are a tool for reli-
able diagnostic and monitoring of these events.  Further studies are required to
evaluate the prognostic significance of these arrhythmias.  
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Baseline V1 CS
Termination with LA ablation 5.0±1.0 5.6±0.5
Termination with LA + RA ablation 4.4±1.0 6.0±0.5
No termination 5.3±1.0 4.8±1.2
p 0.4 0.3
Before termination V1 CS
Termination with LA ablation 5.1±1.0 4.8±0.4
Termination with LA + RA ablation 4.8±1.6 5.5±0.5
No termination 4.4±0.8 4.3±0.7
p 0.7 0.04
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Follow-up (Nb) P Wave (mV) Impedance(Ohm) MAT(Volt) R coefficient ACM(Volt)
Implant (297) 2.8±1.6 614±225 0.8±0.5   
Post-op (269) 2.3±1.2 537±153 0.7±0.4 1 1 0.844 0.7±0.4 1
6-12 Weeks(238) 2.3±1.05 518±146 0.6±0.4 2 2 0.849 0.7±0.4 2
6 months (186) 2.4±1.2 498±142 0.7±0.4 3 3 0.891 0.7±0.5 3
